Keyphrases
Retinal Vein Occlusion
100%
Ranibizumab Injection
100%
Pro Re Nata
100%
Best-corrected Visual Acuity
62%
No Significant Difference
25%
Mean Standard Deviation
25%
Change from Baseline
25%
Ranibizumab
25%
Central Subfield Thickness
25%
Stability Criteria
25%
Macular Edema
12%
Examiner
12%
Visual Outcome
12%
Branch Retinal Vein Occlusion
12%
Visual Gain
12%
Early Treatment Diabetic Retinopathy Study
12%
Difference in Mean
12%
Thickness Reduction
12%
Edema Resolution
12%
Medicine and Dentistry
Best Corrected Visual Acuity
100%
Ranibizumab
100%
Retina Vein Occlusion
100%
Central Retinal Vein Occlusion
20%
Macular Edema
20%
Edema
20%
Diabetic Retinopathy
20%
Branch Retinal Vein Occlusion
20%
Neuroscience
Ranibizumab
100%
Retinal Vein Occlusion
100%
Diabetic Retinopathy
25%
Central Retinal Vein
25%